{"id":"https://openalex.org/W2024601302","doi":"https://doi.org/10.1007/s11096-008-9272-x","title":"Two acute psychotic episodes after administration of bupropion: a case of involuntary rechallenge","display_name":"Two acute psychotic episodes after administration of bupropion: a case of involuntary rechallenge","publication_year":2008,"publication_date":"2008-11-27","ids":{"openalex":"https://openalex.org/W2024601302","doi":"https://doi.org/10.1007/s11096-008-9272-x","mag":"2024601302","pmid":"https://pubmed.ncbi.nlm.nih.gov/19039677"},"language":"en","primary_location":{"id":"doi:10.1007/s11096-008-9272-x","doi":"https://doi.org/10.1007/s11096-008-9272-x","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11096-008-9272-x","pdf_url":null,"source":{"id":"https://openalex.org/S53439352","display_name":"Pharmacy World & Science","issn_l":"0167-6555","issn":["0167-6555","0928-1231","1573-739X","2214-7268"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy World &amp; Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034107629","display_name":"Herv\u00e9 Javelot","orcid":"https://orcid.org/0000-0002-2682-7677","observed_orcids":["https://orcid.org/0000-0002-2682-7677"]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]}],"countries":["BF"],"is_corresponding":true,"raw_author_name":"Herv\u00e9 Javelot","raw_affiliation_strings":["Secteur Pharmacie, Etablissement Public Sant\u00e9 Alsace Nord, 67170 Brumath, France. herve.javelot@ch-epsan.fr","Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secteur Pharmacie, Etablissement Public Sant\u00e9 Alsace Nord, 67170 Brumath, France. herve.javelot@ch-epsan.fr","institution_ids":[]},{"raw_affiliation_string":"Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)","institution_ids":["https://openalex.org/I4210131203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056084981","display_name":"Alexandre Baratta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]}],"countries":["BF"],"is_corresponding":false,"raw_author_name":"Alexandre Baratta","raw_affiliation_strings":["Secteur G06, Etablissement Public Sant\u00e9 Alsace Nord (EPSAN), 67170, Brumath, France","Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secteur G06, Etablissement Public Sant\u00e9 Alsace Nord (EPSAN), 67170, Brumath, France","institution_ids":[]},{"raw_affiliation_string":"Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)","institution_ids":["https://openalex.org/I4210131203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062666209","display_name":"Luisa Weiner","orcid":"https://orcid.org/0000-0002-1178-5929","observed_orcids":["https://orcid.org/0000-0002-1178-5929"]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]}],"countries":["BF"],"is_corresponding":false,"raw_author_name":"Luisa Weiner","raw_affiliation_strings":["Secteur G03, Etablissement Public Sant\u00e9 Alsace Nord (EPSAN), 67170, Brumath, France","Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secteur G03, Etablissement Public Sant\u00e9 Alsace Nord (EPSAN), 67170, Brumath, France","institution_ids":[]},{"raw_affiliation_string":"Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)","institution_ids":["https://openalex.org/I4210131203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010240412","display_name":"Thierry Javelot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thierry Javelot","raw_affiliation_strings":["Secteur 38G11, Centre Psychoth\u00e9rapique du Vion, 38110, Saint Clair de La Tour, France","Centre Psychoth\u00e9rapique du Vion"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secteur 38G11, Centre Psychoth\u00e9rapique du Vion, 38110, Saint Clair de La Tour, France","institution_ids":[]},{"raw_affiliation_string":"Centre Psychoth\u00e9rapique du Vion","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110347228","display_name":"Cathy Nonnenmacher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]}],"countries":["BF"],"is_corresponding":false,"raw_author_name":"Cathy Nonnenmacher","raw_affiliation_strings":["Secteur Pharmacie, Etablissement Public Sant\u00e9 Alsace Nord (EPSAN), 67170, Brumath, France","Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secteur Pharmacie, Etablissement Public Sant\u00e9 Alsace Nord (EPSAN), 67170, Brumath, France","institution_ids":[]},{"raw_affiliation_string":"Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)","institution_ids":["https://openalex.org/I4210131203"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111666815","display_name":"Jean-Fr\u00e9d\u00e9ric Westphal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131203","display_name":"Minist\u00e8re De La Sant\u00e9","ror":"https://ror.org/03h83vk17","country_code":"BF","type":"government","lineage":["https://openalex.org/I4210131203"]}],"countries":["BF"],"is_corresponding":false,"raw_author_name":"Jean-Fr\u00e9d\u00e9ric Westphal","raw_affiliation_strings":["Secteur G03, Etablissement Public Sant\u00e9 Alsace Nord (EPSAN), 67170, Brumath, France","Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Secteur G03, Etablissement Public Sant\u00e9 Alsace Nord (EPSAN), 67170, Brumath, France","institution_ids":[]},{"raw_affiliation_string":"Etablissement Public Sant\u00e9 Alsace Nord (EPSAN)","institution_ids":["https://openalex.org/I4210131203"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110265878","display_name":"Micha\u00ebl Messaoudi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Micha\u00ebl Messaoudi","raw_affiliation_strings":["Neuropsychopharmacology Department, ETAP Research Centre, 54500, Vandoeuvre-les-Nancy, France","ETAP Research Centre"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuropsychopharmacology Department, ETAP Research Centre, 54500, Vandoeuvre-les-Nancy, France","institution_ids":[]},{"raw_affiliation_string":"ETAP Research Centre","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5034107629"],"corresponding_institution_ids":["https://openalex.org/I4210131203"],"apc_list":null,"apc_paid":null,"fwci":1.8327,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.83574316,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"31","issue":"2","first_page":"238","last_page":"240"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.8955000042915344,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.020099999383091927,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.01360000018030405,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.9990000128746033},{"id":"https://openalex.org/keywords/substance-induced-psychotic-disorder","display_name":"drug-induced psychosis","score":0.7080000042915344},{"id":"https://openalex.org/keywords/schizoaffective-disorder","display_name":"schizoaffective disorder","score":0.9700000286102295},{"id":"https://openalex.org/keywords/smoking-cessation","display_name":"smoking cessation","score":0.9100000262260437},{"id":"https://openalex.org/keywords/nicotine-withdrawal","display_name":"nicotine withdrawal","score":0.8610000014305115},{"id":"https://openalex.org/keywords/sustained-release-bupropion","display_name":"bupropion sustained release","score":0.8159999847412109},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.9910823106765747},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.787611722946167},{"id":"https://openalex.org/C2780325297","wikidata":"https://www.wikidata.org/wiki/Q834047","display_name":"Schizoaffective disorder","level":3,"score":0.6551920771598816},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6395024061203003},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.6350860595703125},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5479698777198792},{"id":"https://openalex.org/C2909614370","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Acute Psychosis","level":3,"score":0.5316900014877319},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.5271161198616028},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.4786456823348999},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.44863811135292053},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.40345484018325806},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003693","descriptor_name":"Delirium","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D014029","descriptor_name":"Tobacco Use Disorder","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D014029","descriptor_name":"Tobacco Use Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D016642","descriptor_name":"Bupropion","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017831","descriptor_name":"Diagnosis, Dual (Psychiatry)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11096-008-9272-x","doi":"https://doi.org/10.1007/s11096-008-9272-x","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11096-008-9272-x","pdf_url":null,"source":{"id":"https://openalex.org/S53439352","display_name":"Pharmacy World & Science","issn_l":"0167-6555","issn":["0167-6555","0928-1231","1573-739X","2214-7268"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy World &amp; Science","raw_type":"journal-article"},{"id":"pmid:19039677","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19039677","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacy world & science : PWS","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W17444517","https://openalex.org/W37367773","https://openalex.org/W1851739401","https://openalex.org/W1977069632","https://openalex.org/W2009895806","https://openalex.org/W2040237451","https://openalex.org/W2046157549","https://openalex.org/W2052645451","https://openalex.org/W2057509067","https://openalex.org/W2067978628","https://openalex.org/W2069371444","https://openalex.org/W2118375878","https://openalex.org/W2340792417","https://openalex.org/W2413162894","https://openalex.org/W2470865965","https://openalex.org/W4299501461","https://openalex.org/W4401075332"],"related_works":["https://openalex.org/W1973322842","https://openalex.org/W2086888875","https://openalex.org/W2013159535","https://openalex.org/W2069371444","https://openalex.org/W2149864811","https://openalex.org/W2108819089","https://openalex.org/W1969161537","https://openalex.org/W1969886171","https://openalex.org/W2542881898","https://openalex.org/W2795501345"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}
